{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:07:58Z","timestamp":1791976078799,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s12325-021-01624-x","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T09:08:15Z","timestamp":1611824895000},"page":"1415-1424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Rosacea, Germs, and Bowels: A Review on Gastrointestinal Comorbidities and Gut\u2013Skin Axis of Rosacea"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8189-4944","authenticated-orcid":false,"given":"Fang-Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5699-0283","authenticated-orcid":false,"given":"Ching-Chi","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"1624_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1067\/mjd.2002.120625","volume":"46","author":"J Wilkin","year":"2002","unstructured":"Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the national rosacea society expert committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46:584\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1624_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/jidsymp.2011.6","volume":"15","author":"VD Schwab","year":"2011","unstructured":"Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15:53\u201362.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"1624_CR3","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jaad.2017.07.055","volume":"78","author":"AD Holmes","year":"2018","unstructured":"Holmes AD, Spoendlin J, Chien AL, Baldwin H, Chang ALS. Evidence-based update on rosacea comorbidities and their common physiologic pathways. J Am Acad Dermatol. 2018;78:156\u201366.","journal-title":"J Am Acad Dermatol"},{"key":"1624_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jaad.2015.11.004","volume":"74","author":"A Egeberg","year":"2016","unstructured":"Egeberg A, Hansen PR, Gislason GH, Thyssen JP. Clustering of autoimmune diseases in patients with rosacea. J Am Acad Dermatol. 2016;74:667\u201372 (e661).","journal-title":"J Am Acad Dermatol"},{"key":"1624_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.jaad.2017.09.016","volume":"78","author":"R Haber","year":"2018","unstructured":"Haber R, El Gemayel M. Comorbidities in rosacea: a systematic review and update. J Am Acad Dermatol. 2018;78:786\u201392 (e788).","journal-title":"J Am Acad Dermatol"},{"key":"1624_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bjd.14930","volume":"176","author":"A Egeberg","year":"2017","unstructured":"Egeberg A, Weinstock LB, Thyssen EP, Gislason GH, Thyssen JP. Rosacea and gastrointestinal disorders: a population-based cohort study. Br J Dermatol. 2017;176:100\u20136.","journal-title":"Br J Dermatol"},{"key":"1624_CR7","doi-asserted-by":"publisher","first-page":"e16448","DOI":"10.1097\/MD.0000000000016448","volume":"98","author":"FY Wang","year":"2019","unstructured":"Wang FY, Chi CC. Association of rosacea with inflammatory bowel disease: a moose-compliant meta-analysis. Medicine. 2019;98:e16448.","journal-title":"Medicine"},{"key":"1624_CR8","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1002\/bies.201600008","volume":"38","author":"CA O'Neill","year":"2016","unstructured":"O\u2019Neill CA, Monteleone G, McLaughlin JT, Paus R. The gut-skin axis in health and disease: a paradigm with therapeutic implications. BioEssays. 2016;38:1167\u201376.","journal-title":"BioEssays"},{"key":"1624_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3389\/fmicb.2018.01459","volume":"9","author":"I Salem","year":"2018","unstructured":"Salem I, Ramser A, Isham N, Ghannoum MA. The gut microbiome as a major regulator of the gut-skin axis. Front Microbiol. 2018;9:1459.","journal-title":"Front Microbiol"},{"key":"1624_CR10","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3389\/fmicb.2016.01081","volume":"7","author":"JD Forbes","year":"2016","unstructured":"Forbes JD, Van Domselaar G, Bernstein CN. The gut microbiota in immune-mediated inflammatory diseases. Front Microbiol. 2016;7:1081.","journal-title":"Front Microbiol"},{"key":"1624_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.immuni.2009.08.020","volume":"31","author":"V Gaboriau-Routhiau","year":"2009","unstructured":"Gaboriau-Routhiau V, Rakotobe S, L\u00e9cuyer E, et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity. 2009;31:677\u201389.","journal-title":"Immunity"},{"key":"1624_CR12","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3389\/fmicb.2015.01085","volume":"6","author":"DR Samuelson","year":"2015","unstructured":"Samuelson DR, Welsh DA, Shellito JE. Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol. 2015;6:1085.","journal-title":"Front Microbiol"},{"key":"1624_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.chom.2013.12.010","volume":"15","author":"Y-G Kim","year":"2014","unstructured":"Kim Y-G, Udayanga KGS, Totsuka N, Weinberg JB, N\u00fa\u00f1ez G, Shibuya A. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE2. Cell Host Microbe. 2014;15:95\u2013102.","journal-title":"Cell Host Microbe"},{"issue":"Suppl 1","key":"1624_CR14","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1097\/MCG.0000000000000241","volume":"48","author":"M Picardo","year":"2014","unstructured":"Picardo M, Ottaviani M. Skin microbiome and skin disease: the example of rosacea. J Clin Gastroenterol. 2014;48(Suppl 1):S85-86.","journal-title":"J Clin Gastroenterol"},{"key":"1624_CR15","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3109\/00365529709025099","volume":"32","author":"SM Riordan","year":"1997","unstructured":"Riordan SM, McIver CJ, Thomas DH, Duncombe VM, Bolin TD, Thomas MC. Luminal bacteria and small-intestinal permeability. Scand J Gastroenterol. 1997;32:556\u201363.","journal-title":"Scand J Gastroenterol"},{"key":"1624_CR16","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/apt.15133","volume":"49","author":"A Shah","year":"2019","unstructured":"Shah A, Morrison M, Burger D, et al. Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Aliment Pharmacol Ther. 2019;49:624\u201335.","journal-title":"Aliment Pharmacol Ther"},{"key":"1624_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1111\/j.1572-0241.2003.07379.x","volume":"98","author":"A Tursi","year":"2003","unstructured":"Tursi A, Brandimarte G, Giorgetti G. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98:839\u201343.","journal-title":"Am J Gastroenterol"},{"key":"1624_CR18","doi-asserted-by":"publisher","first-page":"e13028","DOI":"10.1111\/nmo.13028","volume":"29","author":"G Losurdo","year":"2017","unstructured":"Losurdo G, Marra A, Shahini E, et al. Small intestinal bacterial overgrowth and celiac disease: a systematic review with pooled-data analysis. Neurogastroenterol Motil. 2017;29:e13028.","journal-title":"Neurogastroenterol Motil"},{"key":"1624_CR19","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1111\/j.1572-0241.2000.03368.x","volume":"95","author":"M Pimentel","year":"2000","unstructured":"Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503\u20136.","journal-title":"Am J Gastroenterol"},{"key":"1624_CR20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1046\/j.1468-3083.2002.00497.x","volume":"16","author":"A Szlachcic","year":"2002","unstructured":"Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol. 2002;16:328\u201333.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1624_CR21","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1572-0241.1998.00220.x","volume":"93","author":"VK Sharma","year":"1998","unstructured":"Sharma VK, Lynn A, Kaminski M, Vasudeva R, Howden CW. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol. 1998;93:220\u20132.","journal-title":"Am J Gastroenterol"},{"key":"1624_CR22","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MIB.0000000000000644","volume":"22","author":"J Spoendlin","year":"2016","unstructured":"Spoendlin J, Karatas G, Furlano RI, Jick SS, Meier CR. Rosacea in patients with ulcerative colitis and Crohn\u2019s disease: a population-based case\u2013control study. Inflamm Bowel Dis. 2016;22:680\u20137.","journal-title":"Inflamm Bowel Dis"},{"key":"1624_CR23","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1111\/jdv.14352","volume":"31","author":"AR J\u00f8rgensen","year":"2017","unstructured":"J\u00f8rgensen AR, Egeberg A, Gideonsson R, Weinstock LB, Thyssen EP, Thyssen JP. Rosacea is associated with Helicobacter pylori: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2017;31:2010\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1624_CR24","first-page":"109","volume":"298","author":"L Beridze","year":"2020","unstructured":"Beridze L, Ebanoidze T, Katsitadze T, Korsantia N, Zosidze N, Grdzelidze N. The role of Helicobacter pylori in rosacea and pathogenetic treatment. Georgian Med News. 2020;298:109\u201312.","journal-title":"Georgian Med News"},{"key":"1624_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3126\/kumj.v10i4.10995","volume":"10","author":"S Bhattarai","year":"2012","unstructured":"Bhattarai S, Agrawal A, Rijal A, Majhi S, Pradhan B, Dhakal SS. The study of prevalence of Helicobacter pylori in patients with acne rosacea. Kathmandu Univ Med J (KUMJ). 2012;10:49\u201352.","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"1624_CR26","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaad.2014.08.028","volume":"72","author":"AM Two","year":"2015","unstructured":"Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part i. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72:749\u201358.","journal-title":"J Am Acad Dermatol"},{"key":"1624_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1046\/j.1468-3083.2000.00090-3.x","volume":"14","author":"RR Bonamigo","year":"2000","unstructured":"Bonamigo RR, Leite CS, Wagner M, Bakos L. Rosacea and Helicobacter pylori: interference of systemic antibiotic in the study of possible association. J Eur Acad Dermatol Venereol. 2000;14:424\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1624_CR28","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1001\/archderm.132.11.1393","volume":"132","author":"K Kolib\u00e1sov\u00e1","year":"1996","unstructured":"Kolib\u00e1sov\u00e1 K, T\u00f3thov\u00e1 I, Baumgartner J, Filo V. Eradication of Helicobacter pylori as the only successful treatment in rosacea. Arch Dermatol. 1996;132:1393.","journal-title":"Arch Dermatol"},{"key":"1624_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1177\/2050640614559262","volume":"3","author":"A Gravina","year":"2015","unstructured":"Gravina A, Federico A, Ruocco E, et al. Helicobacter pylori infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. United Eur Gastroenterol J. 2015;3:17\u201324.","journal-title":"United Eur Gastroenterol J"},{"key":"1624_CR30","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S1438-4221(01)80002-3","volume":"290","author":"WG Dundon","year":"2001","unstructured":"Dundon WG, de Bernard M, Montecucco C. Virulence factors of Helicobacter pylori. Int J Med Microbiol. 2001;290:647\u201358.","journal-title":"Int J Med Microbiol"},{"key":"1624_CR31","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/s12879-018-3232-4","volume":"18","author":"X Yang","year":"2018","unstructured":"Yang X. Relationship between Helicobacter pylori and rosacea: review and discussion. BMC Infect Dis. 2018;18:318.","journal-title":"BMC Infect Dis"},{"key":"1624_CR32","first-page":"2038","volume":"88","author":"WL Peterson","year":"1993","unstructured":"Peterson WL, Barnett CC, Evans DJ Jr, et al. Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol. 1993;88:2038\u201343.","journal-title":"Am J Gastroenterol"},{"key":"1624_CR33","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1056\/NEJM197811092991908","volume":"299","author":"JC Fr\u00f6lich","year":"1978","unstructured":"Fr\u00f6lich JC, Bloomgarden ZT, Oates JA, McGuigan JE, Rabinowitz D. The carcinoid flush. Provocation by pentagastrin and inhibition by somatostatin. N Engl J Med. 1978;299:1055\u20137.","journal-title":"N Engl J Med"},{"key":"1624_CR34","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10620-007-0065-1","volume":"53","author":"R Khoshini","year":"2008","unstructured":"Khoshini R, Dai S-C, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008;53:1443\u201354.","journal-title":"Dig Dis Sci"},{"key":"1624_CR35","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cgh.2008.02.054","volume":"6","author":"A Parodi","year":"2008","unstructured":"Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6:759\u201364.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1624_CR36","first-page":"1603","volume":"89","author":"A Rebora","year":"1994","unstructured":"Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol. 1994;89:1603\u20134.","journal-title":"Am J Gastroenterol"},{"key":"1624_CR37","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/j.jaad.2016.01.059","volume":"75","author":"F Drago","year":"2016","unstructured":"Drago F, De Col E, Agnoletti AF, et al. The role of small intestinal bacterial overgrowth in rosacea: a 3-year follow-up. J Am Acad Dermatol. 2016;75:e113\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"1624_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jaad.2012.11.038","volume":"68","author":"LB Weinstock","year":"2013","unstructured":"Weinstock LB, Steinhoff M. Rosacea and small intestinal bacterial overgrowth: prevalence and response to rifaximin. J Am Acad Dermatol. 2013;68:875\u20136.","journal-title":"J Am Acad Dermatol"},{"key":"1624_CR39","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/jidsymp.2011.7","volume":"15","author":"M Steinhoff","year":"2011","unstructured":"Steinhoff M, Buddenkotte J, Aubert J, et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15:2\u201311.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"1624_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.cgh.2015.09.013","volume":"14","author":"W-Q Li","year":"2016","unstructured":"Li W-Q, Cho E, Khalili H, Wu S, Chan AT, Qureshi AA. Rosacea, use of tetracycline, and risk of incident inflammatory bowel disease in women. Clin Gastroenterol Hepatol. 2016;14:220\u20135 (e223).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1624_CR41","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.clinre.2018.09.009","volume":"43","author":"J Han","year":"2019","unstructured":"Han J, Liu T, Zhang M, Wang A. The relationship between inflammatory bowel disease and rosacea over the lifespan: a meta-analysis. Clin Res Hepatol Gastroenterol. 2019;43:497\u2013502.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1624_CR42","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1038\/jid.2015.53","volume":"135","author":"ALS Chang","year":"2015","unstructured":"Chang ALS, Raber I, Xu J, et al. Assessment of the genetic basis of rosacea by genome-wide association study. J Investig Dermatol. 2015;135:1548\u201355.","journal-title":"J Investig Dermatol"},{"key":"1624_CR43","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1468-3083.2009.03472.x","volume":"24","author":"K Abram","year":"2010","unstructured":"Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol. 2010;24:565\u201371.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1624_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/MIB.0000000000000955","volume":"23","author":"MC Choy","year":"2017","unstructured":"Choy MC, Visvanathan K, De Cruz P. An overview of the innate and adaptive immune system in inflammatory bowel disease. Inflamm Bowel Dis. 2017;23:2\u201313.","journal-title":"Inflamm Bowel Dis"},{"key":"1624_CR45","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1007\/s10620-013-2694-x","volume":"58","author":"SV Rana","year":"2013","unstructured":"Rana SV, Sharma S, Malik A, et al. Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease. Dig Dis Sci. 2013;58:2594\u20138.","journal-title":"Dig Dis Sci"},{"key":"1624_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00004836-200007000-00015","volume":"31","author":"F Castiglione","year":"2000","unstructured":"Castiglione F, Del Vecchio BG, Rispo A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn\u2019s disease. J Clin Gastroenterol. 2000;31:63\u20136.","journal-title":"J Clin Gastroenterol"},{"key":"1624_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1172\/JCI30253","volume":"117","author":"MF Kagnoff","year":"2007","unstructured":"Kagnoff MF. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Investig. 2007;117:41\u20139.","journal-title":"J Clin Investig"},{"key":"1624_CR48","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/pr.2012.133","volume":"72","author":"M Krini","year":"2012","unstructured":"Krini M, Chouliaras G, Kanariou M, et al. HLA class II high-resolution genotyping in Greek children with celiac disease and impact on disease susceptibility. Pediatr Res. 2012;72:625\u201330.","journal-title":"Pediatr Res"},{"key":"1624_CR49","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/nu10070800","volume":"10","author":"L Rodrigo","year":"2018","unstructured":"Rodrigo L, Beteta-Gorriti V, Alvarez N, et al. Cutaneous and mucosal manifestations associated with celiac disease. Nutrients. 2018;10:800.","journal-title":"Nutrients"},{"key":"1624_CR50","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","volume":"198","author":"B Jabri","year":"2017","unstructured":"Jabri B, Sollid LM. T cells in celiac disease. J Immunol. 2017;198:3005\u201314.","journal-title":"J Immunol"},{"key":"1624_CR51","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2007.01.046","volume":"132","author":"T Liebregts","year":"2007","unstructured":"Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology. 2007;132:913\u201320.","journal-title":"Gastroenterology"},{"key":"1624_CR52","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/gut.2006.108712","volume":"56","author":"I Posserud","year":"2007","unstructured":"Posserud I, Stotzer P-O, Bj\u00f6rnsson ES, Abrahamsson H, Simr\u00e9n M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut. 2007;56:802\u20138.","journal-title":"Gut"},{"key":"1624_CR53","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaad.2015.07.009","volume":"73","author":"BM Rainer","year":"2015","unstructured":"Rainer BM, Fischer AH, da Silva DLF, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol. 2015;73:604\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"1624_CR54","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3748\/wjg.v10.i11.1647","volume":"10","author":"JH Wang","year":"2004","unstructured":"Wang JH, Luo JY, Dong L, Gong J, Tong M. Epidemiology of gastroesophageal reflux disease: a general population-based study in Xi\u2019an of northwest china. World J Gastroenterol. 2004;10:1647\u201351.","journal-title":"World J Gastroenterol"},{"key":"1624_CR55","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jaad.2017.02.040","volume":"76","author":"S Li","year":"2017","unstructured":"Li S, Cho E, Drucker AM, Qureshi AA, Li W-Q. Alcohol intake and risk of rosacea in us women. J Am Acad Dermatol. 2017;76:1061\u20137 (e1062).","journal-title":"J Am Acad Dermatol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-021-01624-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-021-01624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T09:03:10Z","timestamp":1614848590000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-021-01624-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["1624"],"URL":"https:\/\/doi.org\/10.1007\/s12325-021-01624-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"27 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}